The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Larson Brent L since 2005.
The trader's CIK number is 1195766.
At the time of the last reporting, Larson Brent L was the VP Finance and CFO of Navidea Biopharmaceuticals, Inc.. (stock ticker symbol NAVB).
Also see all insider trading activities at Navidea Biopharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | NAVB | 0 | $0 | 120,000 | $200,571 | 0 | $0 |
| 2014 | NAVB | 0 | $0 | 41,500 | $81,340 | 170,000 | $65,000 |
| 2013 | NAVB | 5,000 | $6,949 | 0 | $0 | 0 | $0 |
| 2011 | NAVB | 0 | $0 | 12,500 | $34,375 | 120,000 | $27,600 |
| 2010 | NAVB | 0 | $0 | 0 | $0 | 60,000 | $24,600 |
| 2009 | NAVB | 0 | $0 | 0 | $0 | 60,000 | $30,000 |
| 2006 | NAVB | 4,500 | $1,215 | 0 | $0 | 0 | $0 |
| 2005 | NAVB | 20,000 | $6,500 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-12-01 | NAVB | Sale | 12,500 | 1.50 | 18,750 |
| 2015-11-02 | NAVB | Sale | 12,500 | 1.98 | 24,750 |
| 2015-10-01 | NAVB | Sale | 12,500 | 2.27 | 28,375 |
| 2015-09-01 | NAVB | Sale | 12,500 | 1.88 | 23,512 |
| 2015-08-03 | NAVB | Sale | 12,500 | 1.71 | 21,325 |
| 2015-07-01 | NAVB | Sale | 12,500 | 1.61 | 20,137 |
| 2015-06-01 | NAVB | Sale | 12,500 | 1.24 | 15,537 |
| 2015-05-01 | NAVB | Sale | 12,500 | 1.33 | 16,625 |
| 2015-04-01 | NAVB | Sale | 20,000 | 1.58 | 31,560 |
| 2014-12-10 | NAVB | Option Ex | 50,000 | .39 | 19,500 |
| 2014-03-10 | NAVB | Sale | 41,500 | 1.96 | 81,340 |
| 2014-03-10 | NAVB | Option Ex | 50,000 | .49 | 24,500 |
| 2014-01-07 | NAVB | Option Ex | 70,000 | .30 | 21,000 |
| 2013-11-08 | NAVB | Buy | 5,000 | 1.39 | 6,949 |
| 2011-11-01 | NEOP | Sale | 12,500 | 2.75 | 34,375 |
| 2011-11-01 | NEOP | Option Ex | 120,000 | .23 | 27,600 |
| 2010-12-14 | NEOP | Option Ex | 60,000 | .41 | 24,600 |
| 2009-10-22 | NEOP | Option Ex | 60,000 | .50 | 30,000 |
| 2006-05-12 | NEOP | Buy | 4,500 | .27 | 1,215 |
| 2005-12-01 | NEOP | Buy | 5,000 | .25 | 1,250 |
| 2005-05-09 | NEOP | Buy | 15,000 | .35 | 5,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Larson Brent L (VP Finance and CFO of Navidea Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.